This APT1 phosphorylation promotes melanoma invasion in vitro and correlates with advanced tumor grade and metastasis, suggesting APT1 inhibition as a therapeutic strategy for Wnt5a-driven cancers (Figure 3D) (172). The gene discussed is LYPLA1; the disease is cancer.